Comparison of efficacy of pharmacological cardioversion
with antazoline and propafenone versus electrical
cardioversion in atrial fibrillation during cryoablation

Comparison of efficacy of pharmacological cardioversion with antazoline and propafenone versus electrical cardioversion in atrial fibrillation during cryoablation

Bibliographic Details
Main Authors:	Konrad Klocek, Michał Tworek, Katarzyna Klimek, Mateusz Zabochnicki, Krzysztof Milewski, Marta Mazur, Paweł Kaźmierczak, Adam Janas
Format:	Article
Language:	English
Published:	Termedia Publishing House 2024-03-01
Series:	Advances in Interventional Cardiology
Subjects:	antazoline atrial fibrillation cryoablation electrical cardioversion propafenone
Online Access:	https://www.termedia.pl/Comparison-of-efficacy-of-pharmacological-cardioversion-r-nwith-antazoline-and-propafenone-versus-electrical-r-ncardioversion-in-atrial-fibrillation-during-cryoablation,35,52660,1,1.html

Similar Items

Pharmacological Cardioversion With Antazoline in Atrial Fibrillation: The Results of the CANT Study
by: Maciej T. Wybraniec, et al.
Published: (2018-10-01)

Clinical efficacy of antazoline in rapid cardioversion of paroxysmal atrial fibrillation -- a protocol of a single center, randomized, double-blind, placebo-controlled study (the AnPAF Study)
by: Farkowski Michal M, et al.
Published: (2012-09-01)

Systematic review of the safety and efficacy of antazoline in the treatment of atrial fibrillation.
by: Raghad Aldulaymi, et al.
Published: (2022-01-01)

Pharmacological cardioversion of atrial fibrillation paroxysm in elderly and senile patients at prehospital stage
by: Andrei V. Syrov
Published: (2021-03-01)

Propafenone efficacy in treatment of atrial fibrillation paroxysms: a placebo-controlled study
by: Yu. A. Bunin, et al.
Published: (2005-12-01)

Current Status of Internal Cardioversion in Atrial Fibrillation.
by: Andreas Plewan, et al.
Published: (2002-04-01)

Development and Performance Verification of the PBPK Model for Antazoline and Its Metabolite and Its Utilization for Pharmacological Hypotheses Formulating
by: Barbara Wiśniowska, et al.
Published: (2022-03-01)

Propafenone efficacy and safety in restoring and maintaining sinus rhythm in patients with recurrent atrial fibrillation: results of the open, prospective placebo-controlled trial
by: I. G. Fomina, et al.
Published: (2005-04-01)

Propafenone in restoring sinus rhythm among patients with persistent atrial fibrillation. PROMETEY – an open, multicenter, pilot study performed in the Russian Federation
by: I. G. Fomina, et al.
Published: (2005-08-01)

Efficiency and safety of pharmacological cardioversion for atrial fibrillation
by: Aleksei V. Tarasov
Published: (2021-04-01)

Novel Stability-Indicating TLC-Densitometric Method for Quantification of Antazoline and Tetryzoline; Application to Pharmaceutical Formulation
by: Ola G. Hussein, et al.
Published: (2023-01-01)

THE IMPORTANCE OF EARLY CARDIOVERSION OF PAROXYSMAL ATRIAL FIBRILLATION
by: Franc Verovnik
Published: (2002-01-01)

Initial Energy for External Electrical Cardioversion of Atrial Fibrillation
by: Edilberto Figueiredo, et al.
Published: (2002-08-01)

Rivaroxaban in atrial fibrillation cardioversion: an update
by: Lavalle C, et al.
Published: (2019-05-01)

Cardioversion: What to choose? Etomidate or propofol
by: Pushkar M Desai, et al.
Published: (2015-01-01)

Cardioversion in Infantile Atrial Flutter
by: Andaleeb Ara, et al.
Published: (2022-11-01)

EFFICACY AND SAFETY OF SINUS RHYTHM RESTORATION WITH AMIODARONE AND PROPAFENONE IN OUTPATIENTS, ECONOMIC ASPECTS (BASED ON DATA OF N.A. SEMASHKO NORTHERN MEDICAL CLINICAL CENTER)
by: T. A. Istomina, et al.
Published: (2016-01-01)

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY
by: B. A. Tatarskii
Published: (2015-12-01)

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety
by: N. Yu. Mironov, et al.
Published: (2019-01-01)

Analgetic Sedation for Electrical Cardioversion in Emergency Room
by: Kurniawan Agung Yuwono
Published: (2014-03-01)

Cardioversion of atrial fibrillation does not affect obstructive sleep apnea
by: Niklas Höglund, et al.
Published: (2017-04-01)

Electrical Cardioversion in Atrial Fibrillation: Success Rates
by: JRMC Admin, et al.
Published: (2018-09-01)

Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE‐AF) randomized trial
by: Gregory Y. H. Lip, et al.
Published: (2020-06-01)

Association of iron deficiency with atrial fibrillation recurrence after pharmacological cardioversion
by: M. Kh. Valeev, et al.
Published: (2023-07-01)

Comparison of clinical outcomes of Ibutilide-guided cardioversion and direct current synchronized cardioversion after radiofrequency ablation of persistent atrial fibrillation
by: Xing Liu, et al.
Published: (2023-11-01)

Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter
by: Amgad Mentias, et al.
Published: (2021-09-01)

Incidence and Determinants of Spontaneous Cardioversion of Early Onset Symptomatic Atrial Fibrillation
by: Marco Valerio Mariani, et al.
Published: (2022-10-01)

QTc Dynamics Following Cardioversion for Persistent Atrial Fibrillation
by: Arwa Younis, et al.
Published: (2022-06-01)

Suicide attempt of young woman by Propafenone overdose - case report
by: Marcin Wais, et al.
Published: (2023-12-01)

ECG changes following cardioversion and defibrillation
by: Swiss Medical Weekly
Published: (2007-10-01)

Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation – the FinCV-4 study
by: Samuli Jaakkola, et al.
Published: (2022-12-01)

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness
by: N. Yu. Mironov, et al.
Published: (2018-11-01)

Effect of electrical cardioversion on stented coronary artery
by: Sharifkazemi Mohammad, et al.
Published: (2010-06-01)

Body surface mapping of P-waves in sinus rhythm to predict recurrence following cardioversion for atrial fibrillation
by: Ibrahim Antoun, et al.
Published: (2024-07-01)

Electric cardioversion as therapeutic modality in patients with atrial fibrillation
by: Raúl Joaquín Varela García
Published: (2018-08-01)

Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation
by: N. A. Novikova, et al.
Published: (2016-11-01)

Propafenone efficacy in paroxysmal atrial fibrillation
by: V. V. Skibitsky, et al.
Published: (2004-12-01)

Successful Electrical Cardioversion in Late Pregnancy Woman With Supraventricular Tachycardia
by: Dimas Setiaji, et al.
Published: (2024-09-01)

Diurnal QT analysis in patients with sotalol after cardioversion of atrial fibrillation
by: Hanna Lenhoff, et al.
Published: (2021-07-01)

ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2016-01-01)